Cataract prevalence and prevention in Europe: A literature review

Acta Ophthalmologica

Volumn 91, Issue 5, 2013, Pages 395-405

  Prokofyeva, Elena ^a   Wegener, Alfred ^b   Zrenner, Eberhart ^a,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c European Vision Institute EVI (EEIG)   (Belgium)

Author keywords

adverse effect; cataract; cataract surgery; costs; epidemiology; Europe; medications; prevention; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CAFFEINE; CAROTENOID; CHLORPROMAZINE; CORTICOSTEROID; MINERAL; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PLACEBO; TEMPOL; TRACE ELEMENT;

AGE; AGE DISTRIBUTION; ANTERIOR EYE SEGMENT; ANTIOXIDANT ACTIVITY; ASTHMA; BLINDNESS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CATARACT; CATARACT EXTRACTION; CAUCASIAN; CHRONIC BRONCHITIS; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DENSITOMETRY; DIABETES MELLITUS; DIET; DIFFERENTIAL DIAGNOSIS; DISABILITY ADJUSTED LIFE YEARS; DISEASE DURATION; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG MEGADOSE; EAR; EARLY DIAGNOSIS; EDUCATIONAL STATUS; ETHNICITY; EUROPE; GENETIC DISORDER; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; INCIDENCE; LIFESTYLE; LIGHT SCATTERING; MEDICAL RECORD; MINERAL INTAKE; MULTICENTER STUDY (TOPIC); NONHUMAN; NOSE; OBESITY; OCCUPATION; OUTPATIENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHOTOGRAPHY; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RETINA DETACHMENT; RETINA MACULA EDEMA; REVIEW; RISK FACTOR; SAMPLE SIZE; SCHEIMPFLUG PHOTOGRAPHY; SEX DIFFERENCE; SKIN; SMOKING; SOCIOECONOMICS; SUBCAPSULAR CATARACT; SUBCAPSULAR SUBCAPSULAR CATARACT; SYSTEMATIC REVIEW; TREATMENT DURATION; ULTRAVIOLET RADIATION; VITAMIN INTAKE; VITRECTOMY; VITREOUS LOSS; WEIGHT CHANGE;

ADVERSE EFFECT; CATARACT; CATARACT SURGERY; COSTS; EPIDEMIOLOGY; EUROPE; MEDICATIONS; PREVENTION; RISK FACTORS;

CATARACT; EARLY DIAGNOSIS; EUROPE; HUMANS; PREVALENCE; RISK FACTORS;

EID: 84880257294     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02444.x     Document Type: Review

References (107)

1. Abraham AG, Condon NG, &, West Gower E, (2006): The new epidemiology of cataract. Ophthalmol Clin North Am 19: 415-425.
2. Acosta R, Hoffmeister L, Roman R, Comas M, Castilla M, &, Castells X, (2006): Systematic review of population-based studies of the prevalence of cataracts. Arch Soc Esp Oftalmol 81: 509-516.
3. Age-Related Eye Disease Study Research Group (2001): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119: 1417-1436.
4. AREDS (2001): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119: 1439-1452.
5. Arkhangelsk Oblast Administration, Department of Public Health & Medical Information Center (2007): Morbidity of the population of Arkhangelsk Oblast in 2006: statistical data book morbidity of the population of Arkhangelsk Oblast in 2006: statistical data. Arkhangelsk: Arkhangelsk Oblast Administration, Department of Public Health & Medical Information Center 19-140.
6. Arnarsson A, Jonasson F, Sasaki H, Ono M, Jonsson V, Kojima M, Katoh N, &, Sasaki K, (2002): Risk factors for nuclear lens opacification: the Reykjavik Eye Study. Dev Ophthalmol 35: 12-20.
7. Baltussen R, Sylla M, &, Mariotti SP, (2004): Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ 82: 338-345.
8. Bannikova RV, Sannikov AL, &, Konovalov AV, (2002): Characteristics of ophthalmic pathology under the conditions of the European North of Russia. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 3: 35-36.
9. Beebe DC, Holekamp NM, &, Shui YB, (2010): Oxidative damage and the prevention of age-related cataracts. Ophthalmic Res 44: 155-165.
10. Blum M, Kloos C, Muller N, Mandecka A, Berner R, Bertram B, &, Muller UA, (2007): Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002-2004. Ophthalmologe 104: 499-500, 502-494.
11. Bron AJ, Sparrow J, Brown NA, Harding JJ, &, Blakytny R, (1993): The lens in diabetes. Eye (Lond) 7 (Pt 2): 260-275.
12. Busbee BG, Brown MM, Brown GC, &, Sharma S, (2002): Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 109: 606-612; discussion 612-603.
13. de Bustros S, Thompson JT, Michels RG, Enger C, Rice TA, &, Glaser BM, (1988): Nuclear sclerosis after vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol 105: 160-164.
14. Cedrone C, Culasso F, Cesareo M, Mancino R, Ricci F, Cupo G, &, Cerulli L, (1999): Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol 6: 95-103.
15. Chang DF, (2005): Tackling the greatest challenge in cataract surgery. Br J Ophthalmol 89: 1073-1074.
16. Chang JR, Koo E, Agron E, et al., (2011): Risk factors associated with incident cataracts and cataract surgery in the Age-Related Eye Disease Study (AREDS): AREDS Report Number 32. Ophthalmology 118: 2113-2119.
17. Cherfan GM, Michels RG, de Bustros S, Enger C, &, Glaser BM, (1991): Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol 111: 434-438.
18. Chew EY, Williams GA, Burton TC, Barton FB, Remaley NA, &, Ferris FL III, (1992): Aspirin effects on the development of cataracts in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 16. Arch Ophthalmol 110: 339-342.
19. Christen WG, Glynn RJ, Sesso HD, et al., (2010): Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol 128: 1397-1405.
20. Clayman HM, (1982): Intraocular lenses, axial length, and retinal detachment. Am J Ophthalmol 93: 807.
21. Cohen D, Sartral M, Nounou P, Hamar M, Drouard ME, El Alamy A, &, Bendeddouche K, (2000): Evaluation of moderate and severe visual impairments in patients attending an ophthalmology clinic. A prospective study of 1,172 patients. J Fr Ophtalmol 23: 437-443.
22. Congdon N, Broman KW, Lai H, Munoz B, Bowie H, Gilbert D, Wojciechowski R, &, West SK, (2005): Cortical, but not posterior subcapsular, cataract shows significant familial aggregation in an older population after adjustment for possible shared environmental factors. Ophthalmology 112: 73-77.
23. Cumming RG, &, Mitchell P, (1997): Alcohol, smoking, and cataracts: the Blue Mountains Eye Study. Arch Ophthalmol 115: 1296-1303.
24. Das BN, Thompson JR, Patel R, &, Rosenthal AR, (1994): The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent. J R Soc Med 87: 219-222.
25. Delcourt C, Carriere I, Ponton-Sanchez A, Lacroux A, Covacho MJ, &, Papoz L, (2000a): Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liees a l'Age (POLA) study. Arch Ophthalmol 118: 385-392.
26. Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, &, Papoz L, (2000b): Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l'Age. Am J Epidemiol 151: 497-504.
27. Evanger K, Haugen OH, Irgens A, Aanderud L, &, Thorsen E, (2004): Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood. Acta Ophthalmol Scand 82: 449-453.
28. Fattore G, &, Torbica A, (2008): Cost and reimbursement of cataract surgery in Europe: a cross-country comparison. Health Econ 17: S71-S82.
29. Fledelius HC, Jansen EC, &, Thorn J, (2002): Refractive change during hyperbaric oxygen therapy. A clinical trial including ultrasound oculometry. Acta Ophthalmol Scand 80: 188-190.
30. Foster A, (2001): Cataract and "Vision 2020-the right to sight" initiative. Br J Ophthalmol 85: 635-637.
31. Giuffre G, Giammanco R, Di Pace F, &, Ponte F, (1994): Casteldaccia eye study: prevalence of cataract in the adult and elderly population of a Mediterranean town. Int Ophthalmol 18: 363-371.
32. Gothwal VK, Wright TA, Lamoureux EL, &, Pesudovs K, (2011): The impact of cataract surgery questionnaire: re-evaluation using Rasch analysis. Acta Ophthalmol 89: 423-428.
33. Grauslund J, (2011): Eye complications and markers of morbidity and mortality in long-term type 1 diabetes. Acta Ophthalmol 89 Thesis 1: 1-19.
34. Grauslund J, Green A, &, Sjolie AK, (2011): Cataract surgery in a population-based cohort of patients with type 1 diabetes: long-term incidence and risk factors. Acta Ophthalmol 89: 25-29.
35. Gunnlaugsdottir E, Arnarsson A, &, Jonasson F, (2010): Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study. Acta Ophthalmol 88: 358-366.
36. Hammond CJ, Snieder H, Spector TD, &, Gilbert CE, (2000): Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med 342: 1786-1790.
37. Hammond CJ, Duncan DD, Snieder H, de Lange M, West SK, Spector TD, &, Gilbert CE, (2001): The heritability of age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci 42: 601-605.
38. Hankinson SE, Seddon JM, Colditz GA, Stampfer MJ, Rosner B, Speizer FE, &, Willett WC, (1993): A prospective study of aspirin use and cataract extraction in women. Arch Ophthalmol 111: 503-508.
39. Harding JJ, &, van Heyningen R, (1988): Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol 72: 809-814.
40. Health WCoMa (2001): Macroeconomics and health: investing in health for economical development. Geneva, World Health Organization (WHO): Health WCoMa.
41. Hegde KR, &, Varma SD, (2005): Combination of glycemic and oxidative stress in lens: implications in augmentation of cataract formation in diabetes. Free Radic Res 39: 513-517.
42. Heiba IM, Elston RC, Klein BE, &, Klein R, (1993): Genetic etiology of nuclear cataract: evidence for a major gene. Am J Med Genet 47: 1208-1214.
43. Heijl A, &, Leske MC, (2007): Cataract epidemiology. Ophthalmology 114: 201.
44. van Heyningen R, &, Harding JJ, (1986): Do aspirin-like analgesics protect against cataract? A case-control study. Lancet 1: 1111-1113.
45. Heys KR, Friedrich MG, &, Truscott RJ, (2007): Presbyopia and heat: changes associated with aging of the human lens suggest a functional role for the small heat shock protein, alpha-crystallin, in maintaining lens flexibility. Aging Cell 6: 807-815.
46. Hodge WG, Whitcher JP, &, Satariano W, (1995): Risk factors for age-related cataracts. Epidemiol Rev 17: 336-346.
47. Kanthan GL, Wang JJ, Burlutsky G, Rochtchina E, Cumming RG, &, Mitchell P, (2010): Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: the Blue Mountains Eye Study. Acta Ophthalmol 88: 773-778.
48. Kanthan GL, Mitchell P, Burlutsky G, &, Wang JJ, (2011): Fasting blood glucose levels and the long-term incidence and progression of cataract-the Blue Mountains Eye Study. Acta Ophthalmol 89: e434-e438.
49. Kessel L, (2011): Can we meet the future demands for cataract surgery? Acta Ophthalmol 89: e289-e290.
50. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, &, de Jong PT, (1998): Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116: 653-658.
51. Klein BE, Klein R, &, Moss SE, (1998): Correlates of lens thickness: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 39: 1507-1510.
52. Klein BE, Klein R, &, Moss SE, (2000): Lens thickness and five-year cumulative incidence of cataracts: the Beaver Dam Eye Study. Ophthalmic Epidemiol 7: 243-248.
53. Klein BE, Klein R, Lee KE, &, Danforth LG, (2001): Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study. Ophthalmology 108: 1670-1674.
54. Kobelt G, Lundstrom M, &, Stenevi U, (2002): Cost-effectiveness of cataract surgery. Method to assess cost-effectiveness using registry data. J Cataract Refract Surg 28: 1742-1749.
55. Kocur I, &, Resnikoff S, (2002): Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 86: 716-722.
56. Krumpaszky HG, Ludtke R, Mickler A, Klauss V, &, Selbmann HK, (1999): Blindness incidence in Germany. A population-based study from Wurttemberg-Hohenzollern. Ophthalmologica 213: 176-182.
57. Kuoppala J, Falck A, Winblad I, &, Tuulonen A, (2010): The Pyhajarvi Cataract Study II. Criteria for cataract surgery. Acta Ophthalmol [Epub ahead of print].
58. Laitinen A, Laatikainen L, Harkanen T, Koskinen S, Reunanen A, &, Aromaa A, (2009): Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol 88: 463-471.
59. Leibowitz HM, Krueger DE, Maunder LR, et al., (1980): The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 24: 335-610.
60. Leske MC, Chylack LT Jr, &, Wu SY, (1991): The lens opacities case-control study. Risk factors for cataract. Arch Ophthalmol 109: 244-251.
61. Leske MC, Connell AM, Wu SY, Hyman L, &, Schachat A, (1997): Prevalence of lens opacities in the Barbados Eye Study. Arch Ophthalmol 115: 105-111.
62. Maraini G, Sperduto RD, Ferris F, Clemons TE, Rosmini F, &, Ferrigno L, (2008): A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology 115: 599-607 e591.
63. McCarty CA, Nanjan MB, &, Taylor HR, (2000): Attributable risk estimates for cataract to prioritize medical and public health action. Invest Ophthalmol Vis Sci 41: 3720-3725.
64. Michael I, Shmoish M, Walton DS, &, Levenberg S, (2008): Interactions between trabecular meshwork cells and lens epithelial cells: a possible mechanism in infantile aphakic glaucoma. Invest Ophthalmol Vis Sci 49: 3981-3987.
65. Mitchell P, Cumming RG, Attebo K, &, Panchapakesan J, (1997): Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 104: 581-588.
66. Mizdrak J, Hains PG, Truscott RJ, Jamie JF, &, Davies MJ, (2008): Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage. Free Radic Biol Med 44: 1108-1119.
67. Moshetova LK, (2008): Cataract. In:, Moshetova LK, Nesterov AP, &, Ugorov EA, (eds). Clinical ophthalmology guidelines. Moscow: GEOTAR-Media 72-83.
68. Navarro Esteban JJ, Gutierrez Leiva JA, Valero Caracena N, Buendia Bermejo J, Calle Puron ME, &, Martinez Vizcaino VJ, (2007): Prevalence and risk factors of lens opacities in the elderly in Cuenca, Spain. Eur J Ophthalmol 17: 29-37.
69. Obazawa H, (1982): Physiopathology of cataracts. Kango Gijutsu 28: 989-994.
70. Obrosova IG, Fathallah L, &, Lang HJ, (1999): Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor. Biochem Pharmacol 58: 1945-1954.
71. OECD (2005): Cataract surgeries, ambulatory in patients. Paris. OECD Publishing.
72. Oishi N, Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Tanimoto T, &, Akagi Y, (2006): Correlation between adult diabetic cataracts and red blood cell aldose reductase levels. Invest Ophthalmol Vis Sci 47: 2061-2064.
73. Pascolini D, &, Mariotti SP, (2011): Global estimates of visual impairment: 2010. Br J Ophthalmol [Epub ahead of print].
74. Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Negrel AD, &, Resnikoff S, (2004): 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11: 67-115.
75. Pokhrel AK, Smith KR, Khalakdina A, Deuja A, &, Bates MN, (2005): Case-control study of indoor cooking smoke exposure and cataract in Nepal and India. Int J Epidemiol 34: 702-708.
76. Praveen MR, Vasavada AR, Shah SK, Shah CB, Patel UP, Dixit NV, &, Rawal S, (2009): Lens thickness of Indian eyes: impact of isolated lens opacity, age, axial length, and influence on anterior chamber depth. Eye (Lond) 23: 1542-1548.
77. Rasanen P, Krootila K, Sintonen H, Leivo T, Koivisto AM, Ryynanen OP, Blom M, &, Roine RP, (2006): Cost-utility of routine cataract surgery. Health Qual Life Outcomes 4: 74.
78. Rautiainen S, Lindblad BE, Morgenstern R, &, Wolk A, (2010): Vitamin C supplements and the risk of age-related cataract: a population-based prospective cohort study in women. Am J Clin Nutr 91: 487-493.
79. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, &, Mariotti SP, (2004): Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.
80. Ruigomez A, Garcia Rodriguez LA, Dev VJ, Arellano F, &, Raniwala J, (2000): Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 11: 620-623.
81. Sasaki K, Kojima M, Sakamoto Y, Fujisawa K, Asano K, Ono M, &, Katoh N, (1997): A current UV-B-related cataract epidemiology study in Japan. Dev Ophthalmol 27: 32-41.
82. Sasaki H, Lin LR, Yokoyama T, Sevilla MD, Reddy VN, &, Giblin FJ, (1998): TEMPOL protects against lens DNA strand breaks and cataract in the x-rayed rabbit. Invest Ophthalmol Vis Sci 39: 544-552.
83. Sasaki H, Jonasson F, Shui YB, et al., (2002): High prevalence of nuclear cataract in the population of tropical and subtropical areas. Dev Ophthalmol 35: 60-69.
84. Schalch W, &, Chylack LT, (2003): Antioxidant micronutrients and cataract. Review and comparison of the AREDS and REACT cataract studies]. Ophthalmologe 100: 181-189.
85. Shui YB, Holekamp NM, Kramer BC, et al., (2009): The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship to the etiology of nuclear cataracts. Arch Ophthalmol 127: 475-482.
86. Simmons D, Clover G, &, Hope C, (2007): Ethnic differences in diabetic retinopathy. Diabet Med 24: 1093-1098.
87. Smeeth L, Boulis M, Hubbard R, &, Fletcher AE, (2003): A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol 87: 1247-1251.
88. Smith PW, Stark WJ, Maumenee AE, Enger CL, Michels RG, Glaser BM, &, Bonham RD, (1987): Retinal detachment after extracapsular cataract extraction with posterior chamber intraocular lens. Ophthalmology 94: 495-504.
89. Stark WJ Jr, Maumenee AE, Fagadau W, Datiles M, Baker CC, Worthen D, Klein P, &, Auer C, (1984): Cystoid macular edema in pseudophakia. Surv Ophthalmol 28 (Suppl): 442-451.
90. Taylor HR, (1999): Epidemiology of age-related cataract. Eye (Lond) 13 (Pt 3b): 445-448.
91. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Abbey H, &, Emmett EA, (1988): Effect of ultraviolet radiation on cataract formation. N Engl J Med 319: 1429-1433.
92. The Italian-American Cataract Study Group (1991): Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 133: 541-553.
93. Theodoropoulou S, Theodossiadis P, Samoli E, Vergados I, Lagiou P, &, Tzonou A, (2011): The epidemiology of cataract: a study in Greece. Acta Ophthalmol 89: e167-173.
94. Thompson JT, Glaser BM, Sjaarda RN, &, Murphy RP, (1995): Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 119: 48-54.
95. Trautner C, Haastert B, Richter B, Berger M, &, Giani G, (2003): Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci 44: 1031-1034.
96. Truscott RJ, (2003): Human cataract: the mechanisms responsible; light and butterfly eyes. Int J Biochem Cell Biol 35: 1500-1504.
97. Truscott RJ, (2005): Age-related nuclear cataract-oxidation is the key. Exp Eye Res 80: 709-725.
98. Valero MP, Fletcher AE, De Stavola BL, Vioque J, &, Alepuz VC, (2002): Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 132: 1299-1306.
99. Van Effenterre G, Ameline B, Campinchi F, Quesnot S, Le Mer Y, &, Haut J, (1992): Is vitrectomy cataractogenic? Study of changes of the crystalline lens after surgery of retinal detachment. J Fr Ophtalmol 15: 449-454.
100. Varma SD, Hegde KR, &, Kovtun S, (2010): Inhibition of selenite-induced cataract by caffeine. Acta Ophthalmol 88: e245-e249.
101. Varma SD, Kovtun S, &, Hegde KR, (2011): Role of ultraviolet irradiation and oxidative stress in cataract formation-medical prevention by nutritional antioxidants and metabolic agonists. Eye Contact Lens 37: 233-245.
102. Vrensen GF, (2009): Early cortical lens opacities: a short overview. Acta Ophthalmol 87: 602-610.
103. Vrensen G, &, Willekens B, (1990): Biomicroscopy and scanning electron microscopy of early opacities in the aging human lens. Invest Ophthalmol Vis Sci 31: 1582-1591.
104. Waked N, Saad A, Mehanna C, Sleilaty G, &, Kortbaoui R, (2007): [Prevalence, causes, and risk factors for blindness and visual impairment among nursing home residents in Lebanon]. J Fr Ophtalmol 30: 497-502.
105. Wegener A, &, Laser-Junga H, (2009): Photography of the anterior eye segment according to Scheimpflug's principle: options and limitations-a review. Clin Experiment Ophthalmol 37: 144-154.
106. Wood AM, &, Truscott RJ, (1993): UV filters in human lenses: tryptophan catabolism. Exp Eye Res 56: 317-325.
107. Zigler JS Jr, Qin C, Kamiya T, Krishna MC, Cheng Q, Tumminia S, &, Russell P, (2003): Tempol-H inhibits opacification of lenses in organ culture. Free Radic Biol Med 35: 1194-1202.